What type of study is this?

This is a Retrospective cohort study study.

September 10, 2025TransfusionOpen Access

Red blood cell transfusion practice and cardiac comorbidities in patients with myelodysplastic syndromes

View Full Paper

Ask AI

Bookmark

Authors

Retrospective cohort study investigates RBC transfusion use and cardiac comorbidities in MDS patients, suggesting improved strategies are needed.

Nearly 57% of patients with myelodysplastic syndromes received red blood cell transfusions, indicating a significant need for transfusion interventions.
Patients who were transfused had a median hemoglobin of 87 g/L, notably lower than the 105 g/L in those who did not receive transfusions.
The study involved a retrospective cohort analysis of patients aged 18 and older from 2016 to 2018, focusing on transfusion-related outcomes.
Findings highlight that many patients with MDS have cardiac comorbidities, underscoring the necessity for tailored transfusion approaches.

Mo et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark

Retrospective cohort study investigates RBC transfusion use and cardiac comorbidities in MDS patients, suggesting improved strategies are needed.